Literature DB >> 22821222

Glasgow Prognostic Score as a useful prognostic factor after hepatectomy for hepatocellular carcinoma.

Kei Horino1, Toru Beppu, Hideyuki Kuroki, Kosuke Mima, Hirohisa Okabe, Osamu Nakahara, Yoshiaki Ikuta, Akira Chikamoto, Takatoshi Ishiko, Hiroshi Takamori, Hideo Baba.   

Abstract

BACKGROUND: Several previous studies have revealed that the Glasgow Prognostic Score (GPS) is a clinically useful scoring system to predict the prognosis of patients with various kinds of advanced cancers. However, there have been few reports on the relationship between the GPS and prognosis after hepatectomy for hepatocellular carcinoma (HCC). Therefore, we performed an analysis of the relationship between the GPS and prognosis after hepatectomy for HCC.
METHODS: Between January 2005 and December 2009, 352 HCC patients underwent hepatectomy at Kumamoto University Hospital. Nineteen clinicopathologic factors were analyzed, using univariate and multivariate analyses.
RESULTS: Univariate analysis showed that significant risk factors for poor survival included serum albumin level (<3.5 g/dL), tumor size (>35 mm), presence of ascites, portal vein invasion, operation time (>400 min), blood loss (>360 mL), requirement for blood transfusion, and GPS. Multivariate analysis revealed that tumor size [hazard ratio (HR) 3.355; p = 0.003], operation time (HR 2.634; p = 0.006), portal vein invasion (HR 2.419; p = 0.009), and GPS (HR 3.796; p < 0.001) were independent factors for poor prognosis.
CONCLUSION: The GPS was demonstrated to be a statistically significant prognostic factor after hepatectomy for HCC.

Entities:  

Mesh:

Year:  2012        PMID: 22821222     DOI: 10.1007/s10147-012-0451-3

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  25 in total

1.  The Glasgow Prognostic Score is a good predictor of treatment outcome in patients with unresectable pancreatic cancer.

Authors:  Mitsugi Shimoda; Masato Katoh; Junji Kita; Tokihiko Sawada; Keiichi Kubota
Journal:  Chemotherapy       Date:  2010-11-24       Impact factor: 2.544

2.  Prognosis of hepatocellular carcinoma associated with Child class B and C cirrhosis in relation to treatment: a multivariate analysis of 411 patients at a single center.

Authors:  Shinichi Ueno; Gen Tanabe; Kenshuke Nuruki; Makoto Oketani; Yasuji Komorizono; Hirohumi Hokotate; Yoshihiko Fukukura; Yoshirou Baba; Yasuhiro Imamura; Takashi Aikou
Journal:  J Hepatobiliary Pancreat Surg       Date:  2002

3.  Assessment of protein-calorie malnutrition.

Authors:  M Haider; S Q Haider
Journal:  Clin Chem       Date:  1984-08       Impact factor: 8.327

4.  Usefulness of a modified inflammation-based prognostic system for predicting postoperative mortality of patients undergoing surgery for primary hepatocellular carcinoma.

Authors:  Mitsuru Ishizuka; Keiichi Kubota; Junji Kita; Mitsugi Shimoda; Masato Kato; Tokihiko Sawada
Journal:  J Surg Oncol       Date:  2011-01-15       Impact factor: 3.454

5.  A simple, noninvasively determined index predicting hepatic failure following liver resection for hepatocellular carcinoma.

Authors:  Tsuyoshi Ichikawa; Takahiro Uenishi; Shigekazu Takemura; Kazuki Oba; Masao Ogawa; Shintaro Kodai; Hiroji Shinkawa; Hiromu Tanaka; Takatsugu Yamamoto; Shogo Tanaka; Satoshi Yamamoto; Seikan Hai; Taichi Shuto; Kazuhiro Hirohashi; Shoji Kubo
Journal:  J Hepatobiliary Pancreat Surg       Date:  2008-12-13

6.  Resection margin and recurrence-free survival after liver resection of colorectal metastases.

Authors:  Andrea Muratore; Dario Ribero; Giuseppe Zimmitti; Alfredo Mellano; Serena Langella; Lorenzo Capussotti
Journal:  Ann Surg Oncol       Date:  2009-10-22       Impact factor: 5.344

7.  Hepatic steatosis, body mass index and long term outcome in patients undergoing hepatectomy for colorectal liver metastases.

Authors:  S Pathak; J M F Tang; M Terlizzo; G J Poston; Hassan Z Malik
Journal:  Eur J Surg Oncol       Date:  2009-10-29       Impact factor: 4.424

8.  Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma.

Authors:  C H Su; S H Tsay; C C Wu; Y M Shyr; K L King; C H Lee; W Y Lui; T J Liu; F K P'eng
Journal:  Ann Surg       Date:  1996-04       Impact factor: 12.969

9.  Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors.

Authors:  Shuji Sumie; Ryoko Kuromatsu; Koji Okuda; Eiji Ando; Akio Takata; Nobuyoshi Fukushima; Yasutomo Watanabe; Masamichi Kojiro; Michio Sata
Journal:  Ann Surg Oncol       Date:  2008-03-07       Impact factor: 5.344

10.  Evaluation of an inflammation-based prognostic score (GPS) in patients with metastatic breast cancer.

Authors:  A M Al Murri; J M S Bartlett; P A Canney; J C Doughty; C Wilson; D C McMillan
Journal:  Br J Cancer       Date:  2006-01-30       Impact factor: 7.640

View more
  16 in total

1.  The modified Glasgow Prognostic Score (mGPS) is a good predictor of indication for palliative bypass surgery in patients with unresectable pancreatic and biliary cancers.

Authors:  Yoshiaki Ikuta; Hiroshi Takamori; Yasuo Sakamoto; Daisuke Hashimoto; Akira Chikamoto; Hideyuki Kuroki; Kazuya Sakata; Keita Sakamoto; Hiromitsu Hayashi; Katsunori Imai; Hidetoshi Nitta; Masahiko Hirota; Keiichiro Kanemitsu; Toru Beppu; Hideo Baba
Journal:  Int J Clin Oncol       Date:  2013-09-03       Impact factor: 3.402

2.  C-reactive protein and hepatocellular carcinoma: analysis of its relationships to tumor factors.

Authors:  Brian I Carr; Hikmet Akkiz; Vito Guerra; Oguz Üsküdar; Sedef Kuran; Ümit Karaoğullarından; Salih Tokmak; Tuğsan Ballı; Abdulalh Ülkü; Tolga Akçam; Anıl Delik; Burcu Arslan; Figen Doran; Kendal Yalçın; Engin Altntaş; Ayşegül Özakyol; Mehmet Yücesoy; Halil İbrahim Bahçeci; Kamil Yalçın Polat; Nazım Ekinci; Halis Şimşek; Necat Örmeci; Abdulalh Sonsuz; Mehmet Demir; Murat Kılıç; Ahmet Uygun; Ali Demir; Sezai Yilmaz; Yaman Tokat
Journal:  Clin Pract (Lond)       Date:  2018

3.  Glasgow Prognostic Score and Prognosis After Hepatectomy for Hepatocellular Carcinoma.

Authors:  Tomoyuki Abe; Hirotaka Tashiro; Tsuyoshi Kobayashi; Minoru Hattori; Shintaro Kuroda; Hideki Ohdan
Journal:  World J Surg       Date:  2017-07       Impact factor: 3.352

4.  Glasgow prognostic score predicts therapeutic outcome after hepatic resection for hepatocellular carcinoma.

Authors:  Hiroaki Shiba; Takashi Horiuchi; Taro Sakamoto; Kenei Furukawa; Yoshihiro Shirai; Tomonori Iida; Yuki Fujiwara; Koichiro Haruki; Katsuhiko Yanaga
Journal:  Oncol Lett       Date:  2017-04-28       Impact factor: 2.967

5.  Serum levels of inflammatory markers CRP, ESR and albumin in relation to survival for patients with hepatocellular carcinoma.

Authors:  Hikmet Akkiz; Brian I Carr; Harika G Bag; Ümit Karaoğullarından; Kendal Yalçın; Nazim Ekin; Ayşegül Özakyol; Engin Altıntaş; Hatice Y Balaban; Halis Şimşek; Ahmet Uyanıkoğlu; Ayhan Balkan; Sedef Kuran; Oğuz Üsküdar; Yakup Ülger; Burak Güney; Anil Delik
Journal:  Int J Clin Pract       Date:  2020-12-12       Impact factor: 2.503

Review 6.  Red blood cell transfusions and the survival in patients with cancer undergoing curative surgery: a systematic review and meta-analysis.

Authors:  Fausto Petrelli; Michele Ghidini; Antonio Ghidini; Giovanni Sgroi; Ivano Vavassori; Daniela Petrò; Mary Cabiddu; Alberto Aiolfi; Gianluca Bonitta; Alberto Zaniboni; Emanuele Rausa
Journal:  Surg Today       Date:  2021-01-03       Impact factor: 2.549

7.  Tumor multifocality and serum albumin levels can identify groups of patients with hepatocellular carcinoma and portal vein thrombosis having distinct survival outcomes.

Authors:  B I Carr; V Guerra; R Donghia; S Yilmaz
Journal:  Ann Med Surg (Lond)       Date:  2021-06-02

8.  DNA hypermethylation of zygote arrest 1 (ZAR1) in hepatitis C virus positive related hepatocellular carcinoma.

Authors:  Keiko Takagi; Kyoko Fujiwara; Tadatoshi Takayama; Takao Mamiya; Masayoshi Soma; Hiroki Nagase
Journal:  Springerplus       Date:  2013-04-10

9.  The relationship between Glasgow Prognostic Score and serum tumor markers in patients with advanced non-small cell lung cancer.

Authors:  Ai-Gui Jiang; Hong-Lin Chen; Hui-Yu Lu
Journal:  BMC Cancer       Date:  2015-05-10       Impact factor: 4.430

Review 10.  Prognostic Role of Glasgow Prognostic Score in Patients With Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.

Authors:  Mu-Xing Li; Xin-Yu Bi; Zhi-Yu Li; Zhen Huang; Yue Han; Jian-Guo Zhou; Jian-Jun Zhao; Ye-Fan Zhang; Hong Zhao; Jian-Qiang Cai
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.